Pharma Reviews: Short-term hit likely for pharma

In this scenario, the pharma industry is concerned about the rise in costs. ... be hit post GST, said Santosh Dalvi, partner (indirect tax) at KPMG India.
Read more: Short-term hit likely for pharma